Glecaprevir/Pibrentasvir Fixed-dose Combination Treatment for Acute Hepatitis C Virus Infection
Clinical trial NCT04042740 · COMPLETED
Trial details
- NCT number
- NCT04042740
- Sponsor
- Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-20
- Primary completion
- 2023-05-18
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.